Quell Therapeutics Advances QEL-001, Its Multi-Modular Engineered CAR-Treg Cell Therapy, Into Efficacy Cohort Of LIBERATE Phase 1/2 Trial In Liver Tra...

Progress in the LIBERATE trial was presented at the American Transplant

Related Keywords

Fueyo ,Asturias ,Spain ,United States ,Belgium ,United Kingdom ,London ,City Of ,Philadelphia ,Pennsylvania ,American ,Luke Devey ,Frazer Hall ,Corey Davis ,Sandi Greenwood ,Luke Henry ,Astrazeneca ,American Transplant Congress ,Therapeutics Ltd ,American Transplant ,Quell Therapeutics Ltd ,Data Safety ,Monitoring Board ,Academic Director ,Liver Studies ,Kings College London ,Chief Medical Officer ,Quell Therapeutics ,Chief Business ,Mark Swallow ,